European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

The European/Canadian Glatiramer Acetate Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences